Avalo Therapeutics, Inc. (AVTX)
13.46
+0.60
(+4.67%)
USD |
NASDAQ |
Apr 29, 12:19
Avalo Therapeutics Market Cap : 306.73M for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.451B |
| AbbVie, Inc. | 360.53B |
| Relmada Therapeutics, Inc. | 766.75M |
| Theravance Biopharma, Inc. | 860.45M |
| Corcept Therapeutics, Inc. | 5.001B |
Market Cap Related Metrics
| PS Ratio | 3071.73 |
| Price to Book Value | 3.693 |
| Price | 13.46 |
| Earnings Yield | -45.29% |